pharmaphorum June 16, 2025
23andMe’s co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging victorious in a bidding war for the bankrupt company.
Wojcicki’s non-profit organisation TTAM Research Institute won the auction with a bid of $305 million for the genetic testing firm, topping an offer tabled by pharma company Regeneron.
Earlier this year, Regeneron won an earlier auction with a $256 million bid, but Wojcicki persuaded the court overseeing 23andMe’s bankruptcy that it was unfair, as TTAM had been prohibited from putting forward an offer over $250 million due to concerns about the group’s financial resources.
Armed with additional financial backing from an unidentified ‘blue chip’ investor, TTAM is now on course to take full...
Today's Sponsors
Today's Sponsor